Stock DNA
Healthcare Services
INR 711 Cr (Micro Cap)
31.00
63
0.00%
0.01
15.01%
4.47
Total Returns (Price + Dividend) 
Gaudium IVF for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Gaudium IVF and Women Health Ltd is Rated Sell
Gaudium IVF and Women Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Gaudium IVF and Women Health Ltd Reports Strong Quarterly Turnaround with Robust Revenue and Profit Growth
Gaudium IVF and Women Health Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, reversing a prior negative trend with robust revenue growth and significant profit expansion. This turnaround has been reflected in an upgraded Mojo Grade from Strong Sell to Sell, signalling cautious optimism among investors despite ongoing challenges in the healthcare services sector.
Read More
Gaudium IVF and Women Health Ltd is Rated Strong Sell
Gaudium IVF and Women Health Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Nov-2026 | Source : BSEGaudium IVF and Women Health Limited has informed the Exchange about Newspaper Publication for the Notice of Postal Ballot remote e-voting information and form PAS-1 (Public Notice)
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-Nov-2026 | Source : BSEGaudium IVF and Women Health Limited has informed the Exchange about audio recording of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
16-Nov-2026 | Source : BSENotice of Postal Ballot dated November 16 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.0%)
Held by 6 FIIs (1.19%)
Manika Khanna (70.73%)
Gdn Ventures Llp (4.26%)
18.19%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 105.12% vs -38.29% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 393.98% vs -78.53% in Jun 2026
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 21.32% vs 12.98% in Mar 2025
YoY Growth in year ended Mar 2026 is 19.65% vs 11.96% in Mar 2025